Data / Drug companies / Geri-Care Pharmaceuticals, Corp
Geri-Care Pharmaceuticals, Corp: 100 products in the FDA NDC directory, labeler code 57896
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Geri-Care Pharmaceuticals, Corp (labeler code 57896) lists 100 products in the FDA National Drug Code Directory, covering 51 finished drugs by generic name. By type: 100 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on September 1, 2026.
The request: Watch Geri-Care Pharmaceuticals, Corp (FDA labeler code 57896): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 57896
- Products in commercial distribution
- 100
- Packages
- 172
- Finished drugs by generic name
- 51
- Prescription products
- 0
- Over the counter products
- 100
- Flagged as original packager
- 95 of 95 products that carry the flag
- Started marketing in the last 12 months
- 11
- Products with a marketing end date set
- 5
- Earliest marketing start
- January 1, 1989
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 85 | 85% |
| Generic drugs (ANDA) | 15 | 15% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 100 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 22 | 22% |
| Liquid | 22 | 22% |
| Suspension | 10 | 10% |
| Tablet, film coated | 7 | 7% |
| Tablet, chewable | 6 | 6% |
| Ointment | 5 | 5% |
| Capsule, liquid filled | 4 | 4% |
| Gel | 3 | 3% |
| Cream | 3 | 3% |
| Patch | 3 | 3% |
| Tablet, coated | 3 | 3% |
| Solution/ drops | 2 | 2% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Childrens Acetaminophen | 57896-155 | Tablet, chewable | Over the counter monograph drugs | September 1, 2026 |
| Esomeprazole | 57896-740 | Capsule, delayed release | Generic drugs (ANDA) | August 19, 2026 |
| Mucus relief | 57896-718 | Tablet | Over the counter monograph drugs | August 1, 2026 |
| Lidocaine Pain Relief Patch | 57896-163 | Patch | Over the counter monograph drugs | May 1, 2026 |
| Lidocaine Pain Relief Patch | 57896-161 | Patch | Over the counter monograph drugs | May 1, 2026 |
| Magnesium Citrate | 57896-266 | Liquid | Over the counter monograph drugs | January 1, 2026 |
| Antacid and antigas | 57896-666 | Liquid | Over the counter monograph drugs | December 1, 2025 |
| Antacid and antigas | 57896-662 | Liquid | Over the counter monograph drugs | December 1, 2025 |
| Antacid and antigas | 57896-655 | Liquid | Over the counter monograph drugs | December 1, 2025 |
| Geri Care Tussin CF Max | 57896-596 | Liquid | Over the counter monograph drugs | December 1, 2025 |
| GeriCare Tussin DM Max | 57896-591 | Liquid | Over the counter monograph drugs | December 1, 2025 |
| Ear Wax Removal Drops | 57896-339 | Solution/ drops | Over the counter monograph drugs | September 1, 2025 |
| Cetirizine HCl | 57896-992 | Tablet, film coated | Generic drugs (ANDA) | April 24, 2025 |
| Geri Care Medicated Pads | 57896-115 | Patch | Over the counter monograph drugs | February 6, 2025 |
| Extra Strength Acetaminophen | 57896-219 | Tablet | Over the counter monograph drugs | November 1, 2024 |
| Heartburn relief | 57896-565 | Suspension | Over the counter monograph drugs | July 1, 2024 |
| Geri-kot | 57896-434 | Tablet | Over the counter monograph drugs | July 1, 2024 |
| Extra Strength Night Time Pain Medicine | 57896-224 | Tablet | Over the counter monograph drugs | July 1, 2024 |
| Omeprazole | 57896-659 | Tablet, delayed release | Generic drugs (ANDA) | May 23, 2024 |
| MAXIMUM STRENGTH Antacid | 57896-664 | Suspension | Over the counter monograph drugs | May 1, 2024 |
| Gentle Laxative | 57896-615 | Liquid | Over the counter monograph drugs | April 1, 2024 |
| Famotidine | 57896-319 | Tablet, film coated | Generic drugs (ANDA) | April 1, 2024 |
| Famotidine | 57896-317 | Tablet, film coated | Generic drugs (ANDA) | March 1, 2024 |
| Childrens Chewable Acetaminophen | 57896-148 | Tablet, chewable | Over the counter monograph drugs | February 1, 2024 |
| Stool Softener | 57896-411 | Capsule, liquid filled | Over the counter monograph drugs | January 1, 2024 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.